ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.

Deedwania Prakash

University of California, San Francisco, School of Medicine, Fresno, California, USA.

Ann Intern Med. 2011 Aug 16;155(4):JC2-12. doi: 10.7326/0003-4819-155-4-201108160-02012.

Abstract

摘要

相似文献

Ann Intern Med. 2011 Aug 16;155(4):JC2-12. doi: 10.7326/0003-4819-155-4-201108160-02012.

Ann Intern Med. 2010 Dec 21;153(12):JC6-11. doi: 10.7326/0003-4819-153-12-201012210-02011.

Ann Intern Med. 2010 Feb 16;152(4):JC-213. doi: 10.7326/0003-4819-152-4-201002160-02013.

Arch Intern Med. 2008 Nov 24;168(21):2368-75. doi: 10.1001/archinte.168.21.2368.

Herz. 2007 Feb;32(1):51-7. doi: 10.1007/s00059-007-2843-5.

Diabetes Metab Res Rev. 2009 Feb;25(2):112-26. doi: 10.1002/dmrr.937.

J Nephrol. 2008 Nov-Dec;21(6):826-35.

Curr Med Res Opin. 2004 Jun;20(6):919-30. doi: 10.1185/030079904125003908.

Ann Intern Med. 2009 Oct 20;151(8):JC4-8. doi: 10.7326/0003-4819-151-8-200910200-02008.

Ann Intern Med. 2009 Apr 21;150(8):JC4-8. doi: 10.7326/0003-4819-150-8-200904210-02008.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。